2021
DOI: 10.1080/17843286.2020.1868906
|View full text |Cite
|
Sign up to set email alerts
|

Organisation and quality monitoring for point-of-care testing (POCT) in Belgium: proposal for an expansion of the legal framework for POCT into primary health care

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 22 publications
0
4
0
Order By: Relevance
“…[ 34 , 35 ] Third, different rapid point-of-care tests with high sensitivity and specificity have been developed to distinguish between bacterial and viral aetiology for some specific conditions, and the number of users has increased by 5% yearly since 2014 in North America [ 36 ]. Still, there is no homogeneous access to and use of immunological and microbiological rapid point-of-care testing in the primary care settings among different countries [ 37 ], limiting the generalizability and the comparison of prescribing behaviour.…”
Section: Discussionmentioning
confidence: 99%
“…[ 34 , 35 ] Third, different rapid point-of-care tests with high sensitivity and specificity have been developed to distinguish between bacterial and viral aetiology for some specific conditions, and the number of users has increased by 5% yearly since 2014 in North America [ 36 ]. Still, there is no homogeneous access to and use of immunological and microbiological rapid point-of-care testing in the primary care settings among different countries [ 37 ], limiting the generalizability and the comparison of prescribing behaviour.…”
Section: Discussionmentioning
confidence: 99%
“…However, there is no legal framework regarding the use of POCT outside of a hospital, even though, when combined with a risk-assessment questionnaire, they may provide more accurate screening and referral. To overcome this lack of regulation, a proposal for POCT to be reimbursed was submitted under the condition that the tests would be carried out within an extended legal framework [ 44 ]. The elimination of regulatory barriers is an important step toward ensuring optimal patient care and the sustainability of pharmacist-led screening.…”
Section: Discussionmentioning
confidence: 99%
“…Point-of-care testing (POCT) is now widely used in the healthcare, medical, and clinical professions for early illness monitoring and rapid commercial diagnostic instruments. [1][2][3] Illness screening and treatment options rely heavily on early detection of disease and tumour biomarkers and rapid diagnosis. 4 In many instances, patients need immediate results from diagnostic tests performed in medical laboratories, even though these tests oen take a long time, necessitate multiple stages of preparation for the sample, and call for sophisticated tools for infrastructural construction and staff with extensive training.…”
Section: Introductionmentioning
confidence: 99%